Detalhe da pesquisa
1.
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
Circulation
; 148(24): 1919-1928, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850397
2.
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD.
Vasc Med
; 29(2): 143-152, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493348
3.
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Lancet
; 400(10367): 1927-1937, 2022 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356632
4.
Rivaroxaban in Peripheral Artery Disease after Revascularization.
N Engl J Med
; 382(21): 1994-2004, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32222135
5.
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
J Vasc Surg
; 77(4): 1107-1118.e2, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470531
6.
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Circulation
; 144(23): 1831-1841, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637332
7.
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
Circulation
; 144(14): 1104-1116, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380322
8.
Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD.
Vasc Med
; 27(4): 343-349, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467452
9.
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
Eur Heart J
; 42(39): 4040-4048, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430972
10.
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Circulation
; 142(23): 2219-2230, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33138628
11.
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.
Circulation
; 149(8): 635-637, 2024 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377256
12.
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
Circulation
; 149(19): 1536-1539, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709838
13.
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
N Engl J Med
; 376(13): 1211-1222, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28316279
14.
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).
Am Heart J
; 199: 83-91, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754671
15.
Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal functionâ©.
Clin Nephrol
; 89(5): 314-329, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231162
16.
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
N Engl J Med
; 368(6): 513-23, 2013 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23388003
17.
Predicting the risk of venous thromboembolism in patients hospitalized with heart failure.
Circulation
; 130(5): 410-8, 2014 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24970782
18.
Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Am J Hypertens
; 37(6): 438-446, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436491
19.
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
J Am Heart Assoc
; 13(8): e032782, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563380
20.
Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease.
Am J Cardiovasc Drugs
; 23(3): 247-255, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115488